Fund our Innovation – Lunglytics

₹500.00

Lunglytics is a cutting-edge breath analysis device offering non-invasive, rapid, and accurate disease detection. With its potential to revolutionize healthcare and a promising market, Lungytics presents a compelling investment opportunity. This innovation is being developed by students of Sapphire International School, Crossing Republik.
Category:

LungLytics is an innovative, non-invasive breath analyzer that detects early signs of lung cancer by measuring aldehydes in exhaled breath—biomarkers linked to the disease. It delivers instant results via an I2C display, providing a quick and painless diagnostic solution. With its affordable, scalable design, LunLytics is set to revolutionize early cancer detection and address a critical need in the healthcare market. We seek investment to scale production and advance R&D, bringing this life-saving technology to market and capitalizing on the growing demand for early diagnostic tools.

No product has been found!

Related products

Shopping Cart
Scroll to Top